Neuropsychiatric Safety of GLP-1 Agonists in Diabetes and Obesity | Retatrutide News

The study focuses on the neuropsychiatric safety of GLP-1 receptor agonists in adults with diabetes or obesity. This is significant for the development ...
Clinical Trials · October 30, 2026